Using negative pressure wound therapy after knee and hip surgeries
Routine Use of Negative Pressure Wound Therapy in Primary Hip and Knee Arthroplasties; a Randomized Controlled Trial
This study is testing if a special type of wound treatment can help people heal better and have fewer complications after knee or hip surgery compared to regular bandages.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 82 (estimated) |
| Ages | 50 Years and up |
| Sex | All |
| Sponsor | Chinese University of Hong Kong Academic / other |
| Locations | 1 site (Hong Kong) |
| Trial ID | NCT06181097 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the effectiveness of negative pressure wound therapy (NPWT) in reducing wound complications following total knee and total hip arthroplasty. A total of 40 patients will be randomly assigned to receive either NPWT or standard dressing after their surgeries. The study will monitor the incidence of wound complications over a 21-day period, as well as assess the aesthetic appearance and quality of the resulting scars. The goal is to determine if NPWT can improve healing outcomes compared to traditional methods.
Who should consider this trial
Good fit: Ideal candidates are patients scheduled for total knee or total hip arthroplasty at Prince of Wales Hospital in Hong Kong.
Not a fit: Patients with conditions that impair wound healing, such as those on steroids or with a history of hypertrophic scarring, may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce wound complications and improve scar quality for patients undergoing joint replacement surgeries.
How similar studies have performed: Previous studies have shown that negative pressure wound therapy can reduce complications in surgical wounds, suggesting a promising approach in this context.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients undergoing total knee or total hip arthroplasty at Prince of Wales Hospital, Hong Kong. Exclusion Criteria: * Patients using steroid, or other immune modulators that is known to affect wound healing, prior surgery to the knee or hip, skin condition such as eczema that would result in poor healing or widen scars, patients with a known significant history of hypertrophic scarring or keloid.
Where this trial is running
Hong Kong
- The Chinese University of Hong Kong — Hong Kong, Hong Kong (Recruiting)
Study contacts
- Study coordinator: Michael Tim-Yun Ong
- Email: michael.ong@cuhk.edu.hk
- Phone: 26364171
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.